Venture NAV Tracker / Private company
Castle Creek Biosciences
A clinical-stage cell and gene therapy company and Horizon Technology Finance portfolio company.
HeadquartersExton, PA
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type | Principal | Fair value | FV / principal | Rate | Maturity | Non-accrual |
|---|---|---|---|---|---|---|---|
| HRZNHorizon Technology Finance Corporation | senior secured loan | $25.5MMar 31, 2026 · source ↗ | $25.4MMar 31, 2026 · source ↗ | 99.5%Mar 31, 2026 · source ↗ | P+4.25% (12.00% floor, 4.00% ETP)Mar 31, 2026 · source ↗ | Mar 1, 2028Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.